 Primary variable is the QoL these are measured using the EQ-5D-3L which consists of the EQ-5D-index and the EQ visual analogue scale EQ-VAS. The EQ-5D-3L questionnaire is developed by Euroqol Group. Secondary outcome measures are the AROM of the active trunk flexion and trunk extension measured with a bubble inclinometer. Also, the PI will be scored by the patient during flexion and extension by means of the Verbal Pain Scale scaled 0-10 VRS. The outcomes will be measured within 7 weeks in all participants. The measurements take place during week 0 the baseline measurement W0, week 3 the intermediate measurement W3 and finally week 7 the post measurement W7. All participants were fully informed for the research and agreed by signing the informed consent Appendix Ia. The research was approved by the Committee of Medical Ethics University Hospital University of Brussels, B.U.N. 143201627110. 